BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27663966)

  • 21. Industry Financial Relationships in Plastic Surgery: Analysis of the Sunshine Act Open Payments Database.
    Chao AH; Gangopadhyay N
    Plast Reconstr Surg; 2016 Aug; 138(2):341e-348e. PubMed ID: 27465195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Analysis of the Open Payment Database in Neurotology.
    Ziai K; Sahyouni R; Moshtaghi O; Vu K; Goshtasbi K; Ghavami Y; Lee L; Lin HW; Djalilian HR
    Otolaryngol Head Neck Surg; 2018 Feb; 158(2):319-322. PubMed ID: 29389305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Physician Payments Sunshine Act--Two Years of the Open Payments Program.
    Agrawal S; Brown D
    N Engl J Med; 2016 Mar; 374(10):906-9. PubMed ID: 26962725
    [No Abstract]   [Full Text] [Related]  

  • 24. Industry Payments to Physicians for Opioid Products, 2013-2015.
    Hadland SE; Krieger MS; Marshall BDL
    Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Industry Payments to Adult Reconstruction-Trained Orthopedic Surgeons: An Analysis of the Open Payments Database From 2014 to 2019.
    White PB; Iturriaga C; Frane N; Partan MJ; Ononuju U; Mont MA; Bitterman A
    J Arthroplasty; 2021 Nov; 36(11):3788-3795. PubMed ID: 34362596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Physician Payment Sunshine Act: Evaluating Industrial Payments in Radiology.
    Jutras M; Khosa F
    Acad Radiol; 2019 Jan; 26(1):86-92. PubMed ID: 29958777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.
    Pham-Kanter G; Mello MM; Lehmann LS; Campbell EG; Carpenter D
    J Gen Intern Med; 2017 Jul; 32(7):767-774. PubMed ID: 28265803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of current financial relationships between emergency physicians and industry.
    Niforatos JD; Boas S; Hertz S; Ozgur A; Raja AS
    Am J Emerg Med; 2019 Apr; 37(4):722-725. PubMed ID: 30611579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.
    Nusrat S; Syed T; Nusrat S; Chen S; Chen WJ; Bielefeldt K
    JAMA Netw Open; 2018 Dec; 1(8):e186343. PubMed ID: 30646328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Influence of the Sunshine Act on Industry Payments to United States Orthopaedic Sports Medicine Surgeons.
    Partan MJ; White PB; Frane N; Iturriaga CR; Bitterman A
    Arthroscopy; 2021 Jun; 37(6):1929-1936. PubMed ID: 33677022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Industry payments to female pelvic medicine and reconstructive surgeons: an analysis of Sunshine Act open payments from 2014-2017.
    Teplitsky S; Perez T; Leong JY; Xie K; Murphy A; Shenot PJ
    Int Urogynecol J; 2020 Apr; 31(4):799-807. PubMed ID: 31673796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IR and the Sunshine Act: Two-Year Analysis of the Open Payments Database and Comparison with Related Specialties.
    Baadh AS; Baadh PK; Islam S; Katz DS
    J Vasc Interv Radiol; 2017 Feb; 28(2):200-205. PubMed ID: 27993504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective observational study.
    Liu JJ; Bell CM; Matelski JJ; Detsky AS; Cram P
    BMJ; 2017 Oct; 359():j4619. PubMed ID: 29074628
    [No Abstract]   [Full Text] [Related]  

  • 35. Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States.
    Bansal R; Khan R; Scaffidi MA; Gimpaya N; Genis S; Bukhari A; Dhillon J; Dao K; Bonneau C; Grover SC
    Gastrointest Endosc; 2020 Feb; 91(2):266-273. PubMed ID: 31738925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrepancies in spine surgeon conflict of interest disclosures between a national meeting and physician payment listings on device manufacturer web sites.
    Buerba RA; Fu MC; Grauer JN
    Spine J; 2013 Dec; 13(12):1780-8. PubMed ID: 23830826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing industry compensation of cardiothoracic surgeons and interventional cardiologists.
    Parreco J; Donath E; Kozol R; Faber C
    J Surg Res; 2017 Feb; 208():51-59. PubMed ID: 27993217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mining Open Payments Data: Analysis of Industry Payments to Thoracic Surgeons From 2014-2016.
    Na X; Guo H; Zhang Y; Shen L; Wu S; Li J
    J Med Internet Res; 2018 Nov; 20(11):e11655. PubMed ID: 30504119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions with industry under the Sunshine Act: an example from gynecologic oncology.
    Shalowitz DI; Spillman MA; Morgan MA
    Am J Obstet Gynecol; 2016 Jun; 214(6):703-7. PubMed ID: 26902988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
    Checketts JX; Sims MT; Vassar M
    JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.